Growth of cardiac infants with post-surgical chylothorax can be supported using modified fat breast milk with proactive nutrient-enrichment and advancement feeding protocols; an open-label trial. (August 2020)

• Record Type: Journal Article
• Authors: DiLauro, Sara; Russell, Jennifer; McCrindle, Brian W.; Tomlinson, Christopher; Unger, Sharon; O'Connor, Deborah L.
• Is Part Of: Clinical nutrition ESPEN. Volume 38(2020)
• Page Start: 19
• Page End: 27
• Publication Date: 2020-08
• Subjects: Chylothorax -- Breast milk -- Growth -- Congenital heart disease -- Enteral nutrition -- Pediatrics; MFBM modified fat breast milk -- MCT medium chain triglycerides -- LCT long chain triglycerides; Nutritionally induced diseases -- Periodicals; Metabolism -- Disorders -- Periodicals; 616.39005
• DOI: 10.1016/j.clnesp.2020.05.001
• Languages: English
• ISSNs: 2405-4577

Abstract

Summary: Background & aim: Previously we showed that modified fat breast milk (MFBM) facilitated resolution of post-surgical chylothorax in cardiac infants, but their weight-for-age and length-for-age z-scores declined over the ≥6-week treatment duration. Our aim was to evaluate the growth of infants diagnosed with post-surgical chylothorax and fed according to one of two proactive feeding protocols using MFBM or a high medium triglyceride (MCT)-containing formula (standard of care). Methods: In this open-label trial, infants who were receiving >50% of their enteral feeds as breast milk prior to chylothorax diagnosis were randomized to receive their enteral feeds according to one of two proactive MFBM protocols: Target Fortification (n = 8), where the protein concentration of defatted breast milk was measured weekly and multi- and single-nutrient modulars were added to provide 3.5 g/kg/day of protein; or Higher Initial Concentration (n = 8), where defatted breast milk was initially fortified to an energy and nutrient level higher than that of unmodified breast milk (80kcal/100 ml; 2.2 g/100 ml protein). A third nonrandomized group of infants (n = 8) received high MCT formula (68kcal/100 ml; 2.3 g/100 ml protein). The intervention lasted for a minimum of 6-weeks after chest tube removal and continued after discharge. Weekly weight, length and head circumference (HC) measurements were completed. Results: At enrolment, there was no statistically significant differences in mean (±SD) weight-for-age (−1.6 ± 0.9, n = 24), length-for-age (−1.3 ± 0.8), or HC-for-age (−0.9 ± 1.0) z-scores among groups. Changes in mean weight- (−0.3 ± 0.9, n = 23), length- (0.1 ± 0.6) and HC-for-age (0.2 ± 0.6) z-scores did not differ among groups over the treatment period. There was no difference in duration or volume of chest tube drainage across groups. Conclusion: Use of proactive MFBM feeding protocols both resolve chylothorax and support growth in infants following cardiothoracic surgery. Trial registration: ClinicalTrials.gov (NCT02577419).